Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy

Conclusion: Peptide receptor radionuclide therapy can lead to bowel obstruction in patients with mesenteric or peritoneal disease, likely by inducing inflammation. Corticosteroids can potentially play a role in treatment and prophylaxis.

Source: Journal of Nuclear Medicine - December 17, 2020 Category: Nuclear Medicine Authors: Strosberg, J. R., Al-Toubah, T., Pelle, E., Smith, J., Haider, M., Hutchinson, T., Fleming, J. B., El-Haddad, G. Tags: Clinical Source Type: research